Alpha-GPC: Benefits, Dosage, Contraindications

Updated on

Alpha-GPC, or alpha-glycerylphosphorylcholine, is a cholinergic compound naturally produced in the body from choline. Specifically, it is a choline-containing phospholipid that plays a significant role in supporting cell membranes and enhancing cognitive functions, as a crucial precursor of acetylcholine. Acetylcholine is a neurotransmitter involved in various functions, such as memory, learning, attention, sleep, mood regulation, and muscle functions. When ingested, Alpha-GPC is quickly absorbed and easily crosses the blood-brain barrier. Once metabolized, it breaks down into choline and glycerol-1-phosphate, essential components for the proper functioning of the nervous system and the maintenance of cellular integrity. In Europe and the United States, Alpha-GPC is primarily marketed as a dietary supplement. It is highly regarded for its nootropic properties, enhancing cognitive abilities such as memory and attention. Although research on healthy humans is limited, Alpha-GPC has shown significant benefits in elderly patients with mild to moderate dementia. Besides its effects on cognition, Alpha-GPC is gaining interest in sports for its potential to increase muscular power. It is also considered an effective supplement to enhance the efficacy of acetylcholinesterase inhibitors, often used in the treatment of Alzheimer's disease. When added to this standard treatment, Alpha-GPC may improve the behavioral and cognitive symptoms of patients.

Other name(s) 

a:0:{}

Family or group: 

Psuedovitamins


Indications

Rating methodology

EFSA approval.

Several clinical trials (> 2) randomized controlled with double blind, including a significant number of patients (>100) with consistently positive outcomes for the indication.
Several clinical trials (> 2) randomized controlled with double blind, and including a significant number of patients (>100) with positive outcomes for the indication.
One or more randomized studies or multiple cohorts or epidemiological studies with positive outcomes for the indication.
Clinical studies exist but are uncontrolled, with conclusions that may be positive or contradictory.
Lack of clinical studies to date that can demonstrate the indication.


Alzheimer's Disease
✪✪✪✪✪

The efficacy of Alpha-GPC in the treatment of Alzheimer's disease is promising. A meta-analysis of three moderate-sized clinical studies shows that a daily dose of 1200 mg of Alpha-GPC over six months improves cognitive functions, evaluated by the Mini-Mental State Examination (MMSE), compared to a placebo. Moreover, the combination of Alpha-GPC with donepezil (a drug mainly used in the treatment of Alzheimer's disease) over two years demonstrated an improvement in cognitive functions, a reduction in behavioral symptoms, and enhanced functional abilities, compared to treatment with donepezil alone.

Posologie

posologieOral route

posologie1200 mg

duration6 months


Properties


Neurological

full-leaffull-leaffull-leaffull-leaf

Alpha-GPC is known for its beneficial effects on dementia and the improvement of memory and learning. This compound increases plasma levels of choline, thus promoting the production of acetylcholine and phosphatidylcholine, essential for proper neuronal functioning. As a precursor to membrane phospholipids and glycerolipids, Alpha-GPC can enhance the fluidity of neuronal membranes, thereby optimizing nerve cell function. Its cholinergic effects are also recognized for counteracting memory and attention deficiencies induced by anticholinergic drugs such as scopolamine.

Usages associés

Alzheimer's Disease


Safety dosage

Adult: 1200 mg

Alpha-GPC is most commonly used at a dose of 400 mg three times a day for a period of up to six months.


Interactions

Médicaments

Scopolamine: moderate interaction

Alpha-GPC may partially limit the effects of scopolamine on memory and attention impairment.